Sun Pharma Experiences Increased Trading Activity Amidst Challenging Market Conditions
Sun Pharmaceutical Industries Ltd experienced notable trading activity, with over 7.7 million shares traded and a total value of approximately Rs 121.31 crores. The stock opened at Rs 1,599.0, fluctuating between Rs 1,600.2 and Rs 1,556.2, while showing increased investor participation despite a challenging market environment.
Sun Pharmaceutical Industries Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen significant trading activity today. The stock, trading under the symbol SUNPHARMA, recorded a total traded volume of 7,739,543 shares, with a total traded value of approximately Rs 121.31 crores. Opening at Rs 1,599.0, the stock reached a day high of Rs 1,600.2 before dipping to a low of Rs 1,556.2, reflecting a decline of 2.4% during the trading session. Currently, the last traded price stands at Rs 1,560.2, which is 0.52% away from its 52-week low of Rs 1,553.05. Notably, Sun Pharma has underperformed its sector by 1.84% today, while the broader market, represented by the Sensex, has gained 0.41%.
The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. However, there has been a rise in investor participation, with a delivery volume of 232,100 shares on August 29, marking a 14.29% increase compared to the 5-day average delivery volume. With a market capitalization of Rs 3,81,254 crores, Sun Pharmaceutical Industries remains a significant entity in the large-cap segment. Overall, the stock's performance today reflects a challenging environment within the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
